Histological Study on the Therapeutic Effect of Gene Modified Bone Marrow Hemopoeitic Stem Cells (BMHSCs) Versus Unmodified BMHSCs Derived Exosomes in Early Diabetic Retinopathy Male Rat Model
Year: 2025
Type: article
Abstract: Background and Objectives: Globally, one of the main causes of blindness and vision impairment in the working class is diabetic retinopathy (DR). The goal of the current study was to evaluate and investigate the therapeutic benefits of bone marrow hemopoietic stem cells (BMHSCs) modified by RPE65 and CYP46a1 gene versus unmodified BMHSCs derived exosomes in streptozotocin (STZ) induced early diabetic retinopathy (DR) in male albino rat model. Materials and Methods: 32 adult male rats were divided into: Donor Group, Group І (Control Group), Group II (DR Group): given STZ (50 mg/kg), once by intraperitoneal (IP) injection. Group III (DR, BMHSCs-EXOs treated Group): 2 weeks following confirmation of diabetes BMHSCs-EXOs, were injected in 4 doses IP, Group IV (DR, Gene modified BMHSCs treated Group): 2 weeks following confirmation, RPE65 and CYP46a1 transfected BMHSCs injected once IP. Rats were sacrificed 6 weeks, following day of confirmation of diabetes. Electroretinogram (ERG), serological, biochemical, histological, immunohistochemical, morphometric, fluorescent microscopic and statistical studies were performed. Quantitation of RPE65 and CYP46a1 genes and proteins was done. Results: In group II, mean amplitudes of a and b waves in ERG denoted significant increase and decrease respectively, mean values of blood glucose indicated significant increase, mean Lipid peroxidation (LPO) and Glutathione peroxidase (GPx) values indicated significant increase and decrease respectively. Morphological changes indicative of inflammation progressing to degeneration were found. Group III revealed less inflammatory and degenerative changes. Group IV expressed obvious regression of previous changes. Morphological and immunohistochemical data were confirmed morphometrically. Mean RPE65 and CYP46a1 gene values, and RPE65 and CYP46A1 protein values indicated a significant decrease in group II versus all groups, in group III versus groups I and IV. Conclusion: RPE65 and CYP46a1 gene modified BMHSCs therapeutic effect was more pronounced than BMHSCs-EXOs therapeutic effect.
Authors: Maha Baligh Zickri, Zeinab Mohamed Hegab, Hala Gabr Metwally, Nour Mansour Abdelwahab, Hossam El Din Said Kareem, Mohammed Muataz Hameed, layth Ammar AbdulAdeem, Taha Abdul Rahman Yousif, Mohamed Ahmed AbdelRahman, Amal Ahmed Farag
Institutions: Cairo University, Research Institute of Ophthalmology
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4417533914
FWCI:
Cites:
Cited by:
Related to: